PALO ALTO, Calif.--(BUSINESS WIRE)--July 10, 2006--StemCells, Inc. (NASDAQ: STEM) today announced that Rodney Young, Chief Financial Officer, will present a corporate update at the C. E. Unterberg,...
#19: STEM News StemCells, Inc. to Present at the International Society for Stem Cell Research Annual Meeting; Data Will Highlight Extended Lifespan in Batten Mouse Model and the Prospective Isolation of Human Liver Engrafting Cells
PALO ALTO, Calif.--(BUSINESS WIRE)--June 27, 2006--StemCells, Inc. (NASDAQ: STEM) today announced that Nobuko Uchida, Ph.D., Vice President, Stem Cell Biology, is scheduled to make an oral...
PALO ALTO, Calif.--(BUSINESS WIRE)--Dec. 6, 2005--StemCells, Inc. (NASDAQ: STEM) today announced that it will participate in the Harris Nesbitt Focus on Healthcare Conference scheduled for December...
PALO ALTO, Calif.--(BUSINESS WIRE)--Nov. 15, 2005--StemCells, Inc. (NASDAQ: STEM) today announced that it has been selected to be added to the NASDAQ Biotechnology Index(R) (NBI) effective with the...
PALO ALTO, Calif.--(BUSINESS WIRE)--Nov. 4, 2005--StemCells, Inc. (NASDAQ: STEM) today announced that it will participate in IBC Life Sciences' Stem Cell Research Challenges conference scheduled...
PALO ALTO, Calif.--(BUSINESS WIRE)--Nov. 3, 2005--StemCells, Inc. (NASDAQ: STEM) today announced that it will participate in the Rodman & Renshaw Techvest 7th Annual Healthcare Conference scheduled...
PALO ALTO, Calif.--(BUSINESS WIRE)--Oct. 28, 2005--StemCells, Inc. (NASDAQ: STEM) today reported its financial results and reviewed its significant corporate events for the third quarter ended...
#13: STEM News StemCells, Inc. Receives FDA Clearance to Initiate Phase I Clinical Trial of Neural Stem Cells to Treat Batten Disease; First-Ever FDA-Approved Trial to Transplant Human Neural Stem Cells
PALO ALTO, Calif.--(BUSINESS WIRE)--Oct. 20, 2005--StemCells, Inc. (NASDAQ: STEM) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to begin a Phase I...
PALO ALTO, Calif.--(BUSINESS WIRE)--Oct. 18, 2005--StemCells, Inc. (NASDAQ: STEM) today announced that it will participate in the BIO InvestorForum scheduled for October 19-20, 2005, at the Palace...
PALO ALTO, Calif.--(BUSINESS WIRE)--Sept. 30, 2005--StemCells, Inc. (NASDAQ: STEM) today announced that the Nasdaq Stock Market has approved its application to transfer the listing of its common...
PALO ALTO, Calif.--(BUSINESS WIRE)--Sept. 20, 2005--StemCells, Inc. (NASDAQ: STEM) today announced that it will participate in the UBS Global Life Sciences Conference scheduled for September 26-29,...
#9: STEM News Published Study Shows First Direct Link between Human Neural Stem Cells and Restored Motor Function in Spinal Cord Injured Mice; StemCells Inc.'s Adult Human Neural Stem Cells Regenerate Protective Layer Around Nerves Following Spinal Cord Injur
PALO ALTO, Calif.--(BUSINESS WIRE)--Sept. 19, 2005--StemCells, Inc. (Nasdaq: STEM) today announced results of a published study that demonstrates that the Company's proprietary human neural stem...
PALO ALTO, Calif.--(BUSINESS WIRE)--Sept. 19, 2005--StemCells, Inc. (NASDAQ: STEM) today announced the filing with the U.S. Food and Drug Administration (FDA) of an amendment to its initial IND...
PALO ALTO, Calif.--(BUSINESS WIRE)--Sept. 7, 2005--StemCells, Inc. (NASDAQ: STEM) today announced the appointment of Rodney K.B. Young as Chief Financial Officer and Vice President, Finance,...
PALO ALTO, Calif.--(BUSINESS WIRE)--Aug. 31, 2005--StemCells, Inc. (NASDAQ: STEM) today announced that it has received a manufacturing license for its cell processing facility from the State of...
